Log In
Print this Print this

formerly MORAb-047

  Manage Alerts
Collapse Summary General Information
Company Eisai Co. Ltd.
DescriptionAntibody against Botulinum neurotoxin (BNT)
Molecular Target Not available
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Infectious (unspecified)
Indication DetailsTreat infectious diseases
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today